Unternehmen in BERLIN

LINQ MANAGEMENT GMBH

BeobachtenFeed abonnierenFörderungen als CSV

In 0 Bekanntmachungen genannt, seit 1. Januar 2018, aber in keiner als Auftragnehmer eines Zuschlags.

Fördermittel

Kohesio und Finanztransparenzsystem der EU, so gezählt.

11 Förderungen, zusammen 1,9 Mio. €.

QuelleBetragFörderungen
EU-Haushalt (Finanztransparenzsystem)1,9 Mio. €1111
JahrProgrammProjektBetrag und Beleg
2025EU Budget - European CommissionHADEA - European Health and Digital Executive AgencyINNOVATIONS FOR VACCINES AGAINST HELMINTH INFECTIONSINNOVATIONS FOR VACCINES AGAINST HELMINTH INFECTIONS37.520 €Mittelbindung
2025Other European BodiesGHED - Global Health EDCTP3 Joint Undertaking101190791 - COMBAC-AFRICA - COMBATING MULTIDRUG-RESISTANT GRAM-NEGATIVE BACTERIA IN AFRICA THROUGH DIAGNOSTIC AND ANTIMICROBIAL STEWARDSHIP101190791 - COMBAC-AFRICA - COMBATING MULTIDRUG-RESISTANT GRAM-NEGATIVE BACTERIA IN AFRICA THROUGH DIAGNOSTIC AND ANTIMICROBIAL STEWARDSHIP512.498 €Mittelbindung
2023EU Budget - European CommissionRTD - Directorate-General for Research and Innovation101103076 - MARC SE-AFRICA - MITIGATING ANTIMALARIAL RESISTANCE CONSORTIUM IN SOUTH-EAST AFRICA101103076 - MARC SE-AFRICA - MITIGATING ANTIMALARIAL RESISTANCE CONSORTIUM IN SOUTH-EAST AFRICA0 €Mittelbindung
2023EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101080486 - VAX2MUC - NEXT GENERATION VACCINES AGAINST GASTROINTESTINAL MUCOSAL PATHOGENS, USING HELICOBACTER PYLORI AS MODEL PATHOGEN101080486 - VAX2MUC - NEXT GENERATION VACCINES AGAINST GASTROINTESTINAL MUCOSAL PATHOGENS, USING HELICOBACTER PYLORI AS MODEL PATHOGEN211.832 €Mittelbindung
2023EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101080486 - VAX2MUC - NEXT GENERATION VACCINES AGAINST GASTROINTESTINAL MUCOSAL PATHOGENS, USING HELICOBACTER PYLORI AS MODEL PATHOGEN101080486 - VAX2MUC - NEXT GENERATION VACCINES AGAINST GASTROINTESTINAL MUCOSAL PATHOGENS, USING HELICOBACTER PYLORI AS MODEL PATHOGEN198.165 €Mittelbindung
2023EU Budget - European CommissionRTD - Directorate-General for Research and Innovation101103171 - GENPATH AFRICA - GENOMIC SURVEILLANCE TO CONTROL PATHOGEN INFECTIONS IN AFRICA101103171 - GENPATH AFRICA - GENOMIC SURVEILLANCE TO CONTROL PATHOGEN INFECTIONS IN AFRICA0 €Mittelbindung
2023EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101080784 - WORMVACS2.0 - INNOVATIONS FOR VACCINES AGAINST HELMINTH INFECTIONS101080784 - WORMVACS2.0 - INNOVATIONS FOR VACCINES AGAINST HELMINTH INFECTIONS259.874 €Mittelbindung
2023EU Budget - European CommissionHADEA - European Health and Digital Executive Agency101080784 - WORMVACS2.0 - INNOVATIONS FOR VACCINES AGAINST HELMINTH INFECTIONS101080784 - WORMVACS2.0 - INNOVATIONS FOR VACCINES AGAINST HELMINTH INFECTIONS212.624 €Mittelbindung
2019EU Budget - European CommissionRTD - Directorate-General for Research and Innovation874710 - ESPACE - HUMAN CELL ATLAS OF THE PANCREAS874710 - ESPACE - HUMAN CELL ATLAS OF THE PANCREAS178.746 €Mittelbindung
2019EU Budget - European CommissionRTD - Directorate-General for Research and Innovation874710 - ESPACE - HUMAN CELL ATLAS OF THE PANCREAS874710 - ESPACE - HUMAN CELL ATLAS OF THE PANCREAS7.506 €Mittelbindung
2018EU Budget - European CommissionRTD - Directorate-General for Research and Innovation825835 - EUCANCAN - EUCANCAN: A FEDERATED NETWORK OF ALIGNED AND INTEROPERABLE INFRASTRUCTURES FOR THE HOMOGENEOUS ANALYSIS, MANAGEMENT AND SHARING OF GENOMIC ONCOLOGY DATA FOR PERSONALIZED MEDICINE.825835 - EUCANCAN - EUCANCAN: A FEDERATED NETWORK OF ALIGNED AND INTEROPERABLE INFRASTRUCTURES FOR THE HOMOGENEOUS ANALYSIS, MANAGEMENT AND SHARING OF GENOMIC ONCOLOGY DATA FOR PERSONALIZED MEDICINE.295.653 €Mittelbindung

Angaben aus den Bekanntmachungen

0 Nennungen seit 1. Januar 2018, zuletzt am 1. Januar 2018, dieser Organisation zugeordnet. Wie wir zuordnen

Anschrift
FRIEDBERGSTRASSE 35, 14057 BERLIN
USt-IdNr.
DE815651752
Schreibweisen
  • LINQ MANAGEMENT GMBH